Cellosaurus cell line NCU-L-1 (CVCL

Cross-references
Cell line name	NCU-L-1
Synonyms	NCU-L1; Nagoya City University-Leukemia-1
Accession	CVCL_0G11
Resource Identification Initiative	To cite this cell line use: NCU-L-1 (RRID:CVCL_0G11)
Comments	Population: Japanese. Virology: EBV-negative. Doubling time: 20-28 hours (PubMed=27457200). Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Cell type: B-cell; CL=CL_0000236.
Disease	Adult Burkitt leukemia (NCIt: C7954) Burkitt lymphoma (ORDO: Orphanet_543)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	71Y
Category	Cancer cell line
Publications	PubMed=27457200; DOI=10.3109/10428199009050977 Nitta M., Iwaki O., Wakita A., Kodama H., Takeuchi G., Takada K., Mitomo Y., Yamamoto M., Amano M., Murate T., Koike K., Osada H., Ueda R., Shamoto M. A novel cell line (NCU-L-1) from a patient with acute lymphoblastic leukemia, FAB, L3, Burkitt's type. Leuk. Lymphoma 3:67-71(1990) PubMed=19358282; DOI=10.1002/ijc.24351 Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M., Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R. Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC. Int. J. Cancer 125:212-221(2009)
Encyclopedic resources	Wikidata; Q54908292
Entry history
Entry creation	10-Apr-2015
Last entry update	02-May-2024
Version number	11